CRISPincette MultiCancer is an in vitro diagnostic test utilizing ultra-precision CRISPR/Cas9 technology for liquid biopsy-based cancer detection. The assay selectively cleaves wild-type DNA while amplifying target mutant sequences, enabling sensitive identification of circulating tumor DNA across m...
Manufactured by
Seoul, South Korea
GeneCker is a biotechnology company specializing in ultra-precision CRISPR technology and the MUTE-Seq® platform—an ultrasensitive liquid-biopsy NGS solution. From research and development to kit manufacturing, we provide an end-to-end service for advanced cancer genomics. Our flagship CRISPincette MultiCancer kit incorporates both our patented MUTE-Seq® and CRISPR Cas9 technologies to enrich variant-containing DNA fragments for accurate multi-cancer risk assessment. With operations in Korea, China, and other global markets, GeneCker delivers solutions for Multi-Cancer Early Detection (MCED) and Minimal Residual Disease (MRD) monitoring at ~20× higher analytical precision and one-tenth the per-sample cost compared to conventional UMI-based NGS.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing SynsorBio Technology Co., Ltd
China · 3 relevant products
Intelligenome
United States · 5 relevant products
Guangzhou magigen biotechnology Co.,Ltd
China · 7 relevant products
Rapid Viral Detection Systems
United States · 1 relevant product
Xiamen Micalrun Technology Co.,Ltd
China · 2 relevant products
Biosino Bio-Technology and Science Inc.
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
BioChain (Beijing) Science & Technology. Inc.
China · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 6 relevant products
PlexBio Co., Ltd.
Taiwan · 6 relevant products
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 94 closest product alternatives
Beijing SynsorBio Technology Co., Ltd · China
CRISPR-based molecular diagnostic test for tumor detection utilizing proprietary isothermal amplification and microfluidic integration. Enables rapid point-of-care testing with high sensitivity and specificity for oncology screening and monitoring applications.
Intelligenome · United States
CRISPR-based diagnostic assay for oncology applications. Provides molecular detection and monitoring capabilities for cancer-related diagnostics.
Beijing SynsorBio Technology Co., Ltd · China
Single-target CRISPR detection device for point-of-care testing applications. Integrates CRISPR-based molecular detection with microfluidics technology to enable rapid, accurate identification of specific nucleic acid targets in clinical specimens. Designed for decentralized diagnostic workflows requiring minimal infrastructure.
Beijing SynsorBio Technology Co., Ltd · China
A point-of-care testing system utilizing CRISPR technology for rapid nucleic acid detection. The system integrates microfluidics and synthetic biology for accurate identification of genetic sequences in clinical samples.
Guangzhou magigen biotechnology Co.,Ltd · China
Rapid CRISPR-based detection test strip for molecular diagnostics. Enables quick visual detection of nucleic acid targets.
Rapid Viral Detection Systems · United States
Point-of-care liquid biopsy platform for rapid cancer detection with 99% accuracy and high sensitivity. Delivers non-invasive screening results in minutes, enabling early diagnosis across multiple cancer types at a lower cost than conventional test kits.
Xiamen Micalrun Technology Co.,Ltd · China
Cancer screening kits utilizing microfluidic chip, fluorescent qPCR, and isothermal amplification technologies for precision detection of tumor markers and genetic variants. Designed for early cancer diagnosis, treatment selection, and recurrence monitoring across multiple cancer types. Enables rapid, accurate results for clinical screening and personalized oncology applications.
Biosino Bio-Technology and Science Inc. · China
In-vitro diagnostic products specifically developed for detection of multiple cancer types, enabling early identification and treatment planning. The product line supports clinical decision-making in oncology.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cancer screening and early detection. Part of the comprehensive oncology testing portfolio covering multiple cancer types.
BioChain (Beijing) Science & Technology. Inc. · China
Next-generation sequencing-based multiplex cancer screening panel for simultaneous detection of multiple cancer types. This advanced molecular diagnostic test enables comprehensive cancer risk stratification from single blood samples. The product is in development as part of the company's precision oncology pipeline.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A DNA methylation-based molecular diagnostic test designed for early detection and risk assessment across multiple cancer types. The test utilizes proprietary methylation technology to identify cancer signals in biological samples.
Intelligenome · United States
IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.
82 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products